Valneva SE ( VALN) - Stock Earnings
VALN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
VALN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -52.1 million USD | 34.5 million USD |
| 2025Q4 | -58.7 million USD | 56.0 million USD |
| 2026Q1 | -37.4 million USD | 36.0 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VALN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -112.1 million USD | 169.9 million USD |
| 2024 | -12.8 million USD | 176.6 million USD |
| 2025 | -135.2 million USD | 205.0 million USD |
| 2026 Est. | — | — |
VALN
Price: $7.13
52 week price:
Earnings Per Share: -1.86 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 8187
Market Capitalization: 480.8 million